📰 ET Stocks 🟢 BULLISH 🕒 26 Oct 2026, 11:23 AM IST

Tonbo Imaging shares soar another 17% after a 64% listing pop. Buy, sell or hold the stock?

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Tonbo Imaging shares soar another 17% after a 64% listing pop. Buy, sell or hold the stock?

📊

Market & Financial Impact: Tonbo Imaging shares rallied after a strong stock market debut, following heavy demand for its IPO. Investors will track revenue growth, order execution, profitability, working capital and cash flows to assess the defence electronics company’s long-term prospects.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Strong listing gains put Tonbo Imaging in focus, but sustainable growth and profitability will be key to its long-term outlook.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Will oil turn into a lingering problem? Is the world economy, India, or the market prepared?

KYB and KYC: Business behind the wealth creator called ‘Divi’s Lab’ – Part 2, concluding

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Tonbo Imaging shares soar another 17% after a 64% listing pop. Buy, sell or hold the stock?

🔥 More Live Market Stories

[SPORTKING] Analysts/Institutional Investor Meet/Con. Call Updates - Sportking India Limited

[VIDHIING] Cessation - Vidhi Specialty Food Ingredients Limited

[APLAPOLLO] General Updates - APL Apollo Tubes Limited

[GUJALKALI] Trading Window - Gujarat Alkalies and Chemicals Limited

[HCLTECH] Updates - HCL Technologies Limited

[SUDEEPPHRM] Press Release - Sudeep Pharma Limited